Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M V Relling

Showing results (101-110 of 176) with videos related to

Pageof 18
Sort By:
The Pharmacogenomics Journal|February 10, 2016
A genetic factor associated with low final bone mineral density in children after a long-term glucocorticoids treatmentH-W Park, S Tse, W Yang, et al.
Clinical Pharmacology and Therapeutics|July 2, 2010
Genetic variations in GRIA1 on chromosome 5q33 related to asparaginase hypersensitivityS-H Chen, D Pei, W Yang, et al.
Annals of Internal Medicine|April 15, 1997
Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intoleranceC R Yates, E Y Krynetski, T Loennechen, et al.
Mutation Research|September 3, 1998
A human lymphoid leukemia cell line with a V(D)J recombinase-mediated deletion of hprtC L Chen, M H Woo, G A Neale, et al.
Pharmacogenetics|August 1, 1996
Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanismsE Y Krynetski, H L Tai, C R Yates, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
Phase I trial of paclitaxel in children with refractory solid tumors: a Pediatric Oncology Group StudyC A Hurwitz, M V Relling, S D Weitman, et al.
Leukemia|December 13, 2005
Genome-wide approach to identify risk factors for therapy-related myeloid leukemiaA Bogni, C Cheng, W Liu, et al.
Journal of the National Cancer Institute|December 2, 1999
Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locusM V Relling, M L Hancock, G K Rivera, et al.
Seminars in Oncology|February 1, 1993
Clinical pharmacokinetics and pharmacodynamics of anticancer drugs in childrenJ H Rodman, M V Relling, C F Stewart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1999
Phase I targeted systemic exposure study of paclitaxel in children with refractory acute leukemiasM H Woo, M V Relling, D S Sonnichsen, et al.
Pageof 18

Showing results (101-110 of 176) with videos related to

Sort By:
Pageof 18
The Pharmacogenomics Journal|February 10, 2016
A genetic factor associated with low final bone mineral density in children after a long-term glucocorticoids treatmentH-W Park, S Tse, W Yang, et al.
Clinical Pharmacology and Therapeutics|July 2, 2010
Genetic variations in GRIA1 on chromosome 5q33 related to asparaginase hypersensitivityS-H Chen, D Pei, W Yang, et al.
Annals of Internal Medicine|April 15, 1997
Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intoleranceC R Yates, E Y Krynetski, T Loennechen, et al.
Mutation Research|September 3, 1998
A human lymphoid leukemia cell line with a V(D)J recombinase-mediated deletion of hprtC L Chen, M H Woo, G A Neale, et al.
Pharmacogenetics|August 1, 1996
Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanismsE Y Krynetski, H L Tai, C R Yates, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
Phase I trial of paclitaxel in children with refractory solid tumors: a Pediatric Oncology Group StudyC A Hurwitz, M V Relling, S D Weitman, et al.
Leukemia|December 13, 2005
Genome-wide approach to identify risk factors for therapy-related myeloid leukemiaA Bogni, C Cheng, W Liu, et al.
Journal of the National Cancer Institute|December 2, 1999
Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locusM V Relling, M L Hancock, G K Rivera, et al.
Seminars in Oncology|February 1, 1993
Clinical pharmacokinetics and pharmacodynamics of anticancer drugs in childrenJ H Rodman, M V Relling, C F Stewart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1999
Phase I targeted systemic exposure study of paclitaxel in children with refractory acute leukemiasM H Woo, M V Relling, D S Sonnichsen, et al.
Pageof 18